356 related articles for article (PubMed ID: 10669348)
21. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections.
Norrby-Teglund A; Pauksens K; Norgren M; Holm SE
Scand J Infect Dis; 1995; 27(2):125-30. PubMed ID: 7660074
[TBL] [Abstract][Full Text] [Related]
22. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.
Ekelund K; Skinhøj P; Madsen J; Konradsen HB
J Clin Microbiol; 2005 Apr; 43(4):1789-96. PubMed ID: 15815000
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003.
Vlaminckx BJ; van Pelt W; Schellekens JF
Clin Microbiol Infect; 2005 Jul; 11(7):564-8. PubMed ID: 15966975
[TBL] [Abstract][Full Text] [Related]
24. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
Mascini EM; Hazenberg MM; van Dalen A; Verhoef-Verhage LA; van Leeuwen NJ; Verhoef J; van Dijk H
Adv Exp Med Biol; 1997; 418():921-2. PubMed ID: 9331799
[No Abstract] [Full Text] [Related]
25. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.
Mascini EM; Jansze M; Schouls LM; Verhoef J; Van Dijk H
Int J Antimicrob Agents; 2001 Oct; 18(4):395-8. PubMed ID: 11691576
[TBL] [Abstract][Full Text] [Related]
26. [Detection of pyrogenic exotoxin SpeA, SpeB and SpeC genes in Chilean streptococci isolates and their association with clinical manifestations].
Ulloa MT; Giglio MS; Porte L; Santa Cruz A; McNab P; Fica A; Pinto ME; Kawaguchi K; Carmi A
Rev Med Chil; 2000 Jan; 128(1):27-34. PubMed ID: 10883519
[TBL] [Abstract][Full Text] [Related]
27. Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B.
Mascini EM; Jansze M; Verhoef J; van Dijk H
Clin Diagn Lab Immunol; 1999 Nov; 6(6):977-80. PubMed ID: 10548596
[TBL] [Abstract][Full Text] [Related]
28. Streptococcal toxic shock syndrome by an iMLS resistant M type 77 Streptococcus pyogenes in the Netherlands.
Gooskens J; Neeling AJ; Willems RJ; Wout JW; Kuijper EJ
Scand J Infect Dis; 2005; 37(2):85-9. PubMed ID: 15764198
[TBL] [Abstract][Full Text] [Related]
29. Streptococcal pyrogenic exotoxin B cleaves human S-adenosylhomocysteine hydrolase and induces hypermethioninemia.
Hsu JF; Chuang WJ; Shiesh SC; Lin YS; Liu CC; Wang CC; Fu TF; Tsai JH; Tsai WL; Huang YJ; Hsieh YH; Wu JJ; Lin MT; Huang W
J Infect Dis; 2008 Aug; 198(3):367-74. PubMed ID: 18522500
[TBL] [Abstract][Full Text] [Related]
30. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects.
Ekelund K; Skinhøj P; Madsen J; Konradsen HB
Clin Microbiol Infect; 2005 Jul; 11(7):569-76. PubMed ID: 15966976
[TBL] [Abstract][Full Text] [Related]
31. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
O'Loughlin RE; Roberson A; Cieslak PR; Lynfield R; Gershman K; Craig A; Albanese BA; Farley MM; Barrett NL; Spina NL; Beall B; Harrison LH; Reingold A; Van Beneden C;
Clin Infect Dis; 2007 Oct; 45(7):853-62. PubMed ID: 17806049
[TBL] [Abstract][Full Text] [Related]
32. Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction.
Cusumano V; Fera MT; Carbone M; Anzani Ciliberti F; Bellantoni A; Cusumano V
New Microbiol; 2000 Jan; 23(1):37-45. PubMed ID: 10946404
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of group A streptococcal bacteremia with comparison between children and adults.
Huang YC; Huang YC; Chiu CH; Chang LY; Leu HS; Lin TY
J Microbiol Immunol Infect; 2001 Sep; 34(3):195-200. PubMed ID: 11605811
[TBL] [Abstract][Full Text] [Related]
34. Streptococcal toxic shock-like syndrome.
Wolf JE; Rabinowitz LG
Arch Dermatol; 1995 Jan; 131(1):73-7. PubMed ID: 7826100
[TBL] [Abstract][Full Text] [Related]
35. Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters.
Byrne JL; Aagaard-Tillery KM; Johnson JL; Wright LJ; Silver RM
J Reprod Immunol; 2009 Oct; 82(1):74-83. PubMed ID: 19682751
[TBL] [Abstract][Full Text] [Related]
36. Application of the C3-binding motif of streptococcal pyrogenic exotoxin B to protect mice from invasive group a streptococcal infection.
Kuo CF; Tsao N; Cheng MH; Yang HC; Wang YC; Chen YP; Lin KJ
PLoS One; 2015; 10(1):e0117268. PubMed ID: 25629609
[TBL] [Abstract][Full Text] [Related]
37. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region.
Laupland KB; Ross T; Church DL; Gregson DB
Clin Microbiol Infect; 2006 Mar; 12(3):224-30. PubMed ID: 16451408
[TBL] [Abstract][Full Text] [Related]
38. [Tissue infections caused by group A beta hemolytic Streptococcus in a regional hospital of Talca, Chile].
Hasbún S; Arias H; Tapia R
Rev Med Chil; 2000 Nov; 128(11):1215-9. PubMed ID: 11347508
[TBL] [Abstract][Full Text] [Related]
39. The heterogeneity of endemic community pediatric group a streptococcal pharyngeal isolates and their relationship to invasive isolates.
Haukness HA; Tanz RR; Thomson RB; Pierry DK; Kaplan EL; Beall B; Johnson D; Hoe NP; Musser JM; Shulman ST
J Infect Dis; 2002 Apr; 185(7):915-20. PubMed ID: 11920315
[TBL] [Abstract][Full Text] [Related]
40. Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome.
Forni AL; Kaplan EL; Schlievert PM; Roberts RB
Clin Infect Dis; 1995 Aug; 21(2):333-40. PubMed ID: 8562741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
